These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 6325413

  • 1. Inhibition of (Na,K)-ATPase by tetravalent vanadium.
    North P, Post RL.
    J Biol Chem; 1984 Apr 25; 259(8):4971-8. PubMed ID: 6325413
    [Abstract] [Full Text] [Related]

  • 2. Inhibition by vanadium of sodium and potassium dependent adenosinetriphosphatase derived from animal and human tissues.
    Nechay BR, Saunders JP.
    J Environ Pathol Toxicol; 1978 Apr 25; 2(2):247-62. PubMed ID: 216760
    [Abstract] [Full Text] [Related]

  • 3. The fate of cytoplasmic vanadium. Implications on (NA,K)-ATPase inhibition.
    Cantley LC, Aisen P.
    J Biol Chem; 1979 Mar 25; 254(6):1781-4. PubMed ID: 217870
    [Abstract] [Full Text] [Related]

  • 4. Vanadyl (VO2+) and vanadate (VO-3) ions inhibit the brain microsomal Na,K-ATPase with similar affinities. Protection by transferrin and noradrenaline.
    Svoboda P, Teisinger J, Pilăr J, Vyskocil F.
    Biochem Pharmacol; 1984 Aug 01; 33(15):2485-91. PubMed ID: 6087831
    [Abstract] [Full Text] [Related]

  • 5. Vanadyl (VO2+) induced lipoperoxidation in the brain microsomal fraction is not related to VO2+ inhibition of Na,K-ATPase.
    Svoboda P, Teisinger J, Vyskocil F.
    Biochem Pharmacol; 1984 Aug 01; 33(15):2493-7. PubMed ID: 6147142
    [Abstract] [Full Text] [Related]

  • 6. Effects of vanadate on ouabain binding and inhibition of (Na+ + K+)-ATPase.
    Myers TD, Boerth RC, Post RL.
    Biochim Biophys Acta; 1979 Nov 16; 558(1):99-107. PubMed ID: 227460
    [Abstract] [Full Text] [Related]

  • 7. Significance of NADH-vanadate-oxidoreductase of cardiac and erythrocyte cell membranes.
    Erdmann E, Werdan K, Krawietz W, Lebuhn M, Christl S.
    Basic Res Cardiol; 1980 Nov 16; 75(3):460-5. PubMed ID: 6255934
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous bindings of ATP and vanadate to (Na+ + K+)-ATPase. Implications for the reaction mechanism of the enzyme.
    Huang WH, Askari A.
    J Biol Chem; 1984 Nov 10; 259(21):13287-91. PubMed ID: 6092372
    [Abstract] [Full Text] [Related]

  • 9. Vanadium inhibition of human parietal lobe ATPases.
    Janiszewska G, Lachowicz L, Jaskólski D, Gromadzińska E.
    Int J Biochem; 1994 Apr 10; 26(4):551-3. PubMed ID: 8013740
    [Abstract] [Full Text] [Related]

  • 10. Vanadate inhibition of Na+K+. ATPase and K+-dependent p-nitrophenylphosphatase: a kinetic analysis.
    Blázovics A, Vodnyánszky L, Somogyi J, Horváth I.
    Acta Biochim Biophys Acad Sci Hung; 1983 Apr 10; 18(3-4):199-209. PubMed ID: 6331047
    [Abstract] [Full Text] [Related]

  • 11. The optimum pH of renal adenosine triphosphatase in rats: influence of vanadate, noradrenaline and potassium.
    Michell AR, Taylor EA.
    Enzyme; 1982 Apr 10; 28(4):309-16. PubMed ID: 6129969
    [Abstract] [Full Text] [Related]

  • 12. Vanadate effect on the Na,K-ATPase and the Na-K pump in in vitro-grown rat vascular smooth muscle cells.
    Searle BM, Higashino H, Khalil F, Bogden JD, Tokushige A, Tamura H, Kino M, Aviv A.
    Circ Res; 1983 Aug 10; 53(2):186-91. PubMed ID: 6309430
    [Abstract] [Full Text] [Related]

  • 13. Vanadium uptake by yeast cells.
    Bode HP, Friebel C, Fuhrmann GF.
    Biochim Biophys Acta; 1990 Feb 28; 1022(2):163-70. PubMed ID: 2155019
    [Abstract] [Full Text] [Related]

  • 14. The effect of vanadate on human kidney potassium dependent phosphatase.
    Nieder GL, Corder CN, Culp PA.
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jun 28; 307(2):191-7. PubMed ID: 39261
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A study of the vanadate-trapped state of the (Na,K)-ATPase. Evidence against interacting nucleotide site models.
    Smith RL, Zinn K, Cantley LC.
    J Biol Chem; 1980 Oct 25; 255(20):9852-9. PubMed ID: 6253455
    [Abstract] [Full Text] [Related]

  • 17. Metabolism of added orthovanadate to vanadyl and high-molecular-weight vanadates by Saccharomyces cerevisiae.
    Willsky GR, White DA, McCabe BC.
    J Biol Chem; 1984 Nov 10; 259(21):13273-81. PubMed ID: 6386812
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of rat cardiac and renal Na+,K+-ATPase by high sodium concentrations and vanadate.
    Clough DL.
    Life Sci; 1985 Sep 02; 37(9):799-807. PubMed ID: 2993776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.